
The PatientAdvantage Trial Delivery Method
PatientAdvantage
In an industry that is driven by data, finding sites and patients is frustratingly unpredictable. Too many trials are based on the unfulfilled promise of qualified patients and high-performing sites.
PPD’s Accelerated Enrollment Solutions has created a transformative site-patient model that starts with 100 million households of fully-identified patients and a global network of 180+ trial-ready research sites.
Benefits
Increases site enrollment rates by an average of 50% by:
- Pre-qualifying patients before your study begins using our proprietary database of fully identified patients
- Speeding study startup through our centrally managed site infrastructure, with a single contract for all AES sites
- Reducing your site footprint by rapidly replacing non-enrolling sites with others in our network
- Eliminating financial risk by providing a single price per patient at randomization
- Providing therapeutic expertise across a range of chronic ambulatory conditions, including vaccines at 180+ global sites.
AES offers fully identified patients and a centrally-managed global site organization
Together, they are dramatically accelerating patient enrollment, expediting study startup and shortening study timelines
Bringing Greater Value to Our Customers:
Patients are already identified, which means recruitment can begin immediately. There is no lag time waiting for sites to identify patients — a task which strains their resources, falls outside their scope of expertise and delays enrollment timelines.
Benefit:
Direct patient input informs our knowledge base, enabling our marketing communication professionals to craft compelling messages that speak directly to patients’ challenges, desires, concerns and barriers to clinical trial participation.
Benefit:
Our algorithm identifies actual patients near active sites to supplement those in our database, thereby further expanding the potential pool of eligible individuals.
Benefit:
We offer our customers standardized SOPs, enhanced productivity, increased patient enrollment scale and efficiency and access to a broad range of therapeutic expertise.
Benefit:
Fewer sites means lower site costs, higher productivity at each site and cleaner data with less variability.